Compare CURV & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURV | TKNO |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | 7590 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.8M | 138.1M |
| IPO Year | 2021 | 2021 |
| Metric | CURV | TKNO |
|---|---|---|
| Price | $1.74 | $2.89 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $1.59 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 130.1K |
| Earning Date | 03-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.36 | ★ 43.86 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,103,737,000.00 | $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | $0.21 | $13.13 |
| P/E Ratio | $172.00 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $0.94 | $1.91 |
| 52 Week High | $6.69 | $7.48 |
| Indicator | CURV | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 76.75 | 55.17 |
| Support Level | $1.63 | $1.97 |
| Resistance Level | $1.96 | $5.39 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 77.71 | 70.40 |
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.